Novel Treatment Strategies for Glioblastoma
This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, resea...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_77121 | ||
| 005 | 20220111 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20220111s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-2598-3 | ||
| 020 | |a 9783036525990 | ||
| 020 | |a 9783036525983 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-2598-3 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Stylli, Stanley |4 edt | |
| 700 | 1 | |a Stylli, Stanley |4 oth | |
| 245 | 1 | 0 | |a Novel Treatment Strategies for Glioblastoma |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (268 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a This book is a compilation of articles that brings together current knowledge from an international team of contributors who are dedicated investigators exploring novel strategies for the treatment of glioblastoma. These articles describe some of the latest concepts that will provide students, researchers and clinicians with an overview of the therapeutic approaches being developed in the field of neuro-oncology to combat this deadly disease. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a glioblastoma | ||
| 653 | |a glioma | ||
| 653 | |a temozolomide | ||
| 653 | |a radiotherapy | ||
| 653 | |a immunotherapy | ||
| 653 | |a novel therapy | ||
| 653 | |a personalized treatment | ||
| 653 | |a drug repurposing | ||
| 653 | |a invasion | ||
| 653 | |a invadopodia | ||
| 653 | |a ion channels | ||
| 653 | |a gene therapy | ||
| 653 | |a viral vectors | ||
| 653 | |a brain tumor | ||
| 653 | |a nanomedicine | ||
| 653 | |a cancer stem cell | ||
| 653 | |a targeted therapy | ||
| 653 | |a brain cancer | ||
| 653 | |a cell cycle | ||
| 653 | |a differentiation | ||
| 653 | |a proliferation | ||
| 653 | |a RAS | ||
| 653 | |a SRGAP2 | ||
| 653 | |a stem cell | ||
| 653 | |a TP53 | ||
| 653 | |a glioblastoma multiforme | ||
| 653 | |a GBM | ||
| 653 | |a nerve/glial antigen 2 | ||
| 653 | |a NG2 | ||
| 653 | |a CK2 | ||
| 653 | |a CX-4945 | ||
| 653 | |a migration | ||
| 653 | |a CRISPR/Cas9 | ||
| 653 | |a anticancer | ||
| 653 | |a anti-angiogenesis | ||
| 653 | |a thyrointegrin αvβ3 | ||
| 653 | |a PEG | ||
| 653 | |a triazole tetrac | ||
| 653 | |a P-bi-TAT | ||
| 653 | |a P-m-TAT | ||
| 653 | |a tetrac | ||
| 653 | |a one-carbon metabolism | ||
| 653 | |a de novo purine synthesis | ||
| 653 | |a metabolic reprogramming | ||
| 653 | |a metabolic treatment | ||
| 653 | |a vaccine | ||
| 653 | |a immune checkpoint inhibitors | ||
| 653 | |a chimeric antigen receptor (CAR) T cells | ||
| 653 | |a glioblastoma (GB) | ||
| 653 | |a prolyl-oligopeptidase (POP) | ||
| 653 | |a vascular endothelial growth factor (VEGF) | ||
| 653 | |a transforming growth factor-β (TGF-β) | ||
| 653 | |a angiopoietin (Ang) | ||
| 653 | |a endothelial nitric oxide synthase (eNOS) | ||
| 653 | |a newly diagnosed glioblastoma | ||
| 653 | |a recurrent glioblastoma | ||
| 653 | |a new trial design | ||
| 653 | |a drug-inducible gene expression | ||
| 653 | |a Mardepodect | ||
| 653 | |a Regorafenib | ||
| 653 | |a drug targets | ||
| 653 | |a tumor antigens | ||
| 653 | |a renin-angiotensin system | ||
| 653 | |a pluripotent stem cells | ||
| 653 | |a organoids | ||
| 653 | |a cancer stem cells | ||
| 653 | |a cancer stem cell niche | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a n/a | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4740 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/77121 |7 0 |z DOAB: description of the publication |